[go: up one dir, main page]

MX9804871A - Dispositivo transdermico para suministro de flurbiprofeno. - Google Patents

Dispositivo transdermico para suministro de flurbiprofeno.

Info

Publication number
MX9804871A
MX9804871A MX9804871A MX9804871A MX9804871A MX 9804871 A MX9804871 A MX 9804871A MX 9804871 A MX9804871 A MX 9804871A MX 9804871 A MX9804871 A MX 9804871A MX 9804871 A MX9804871 A MX 9804871A
Authority
MX
Mexico
Prior art keywords
flurbiprofen
delivery
transdermal device
acrylate
effective amount
Prior art date
Application number
MX9804871A
Other languages
English (en)
Inventor
Jochem J Effing
Eberhard A Gruhlke
Wolfgang Welsing
Kristin J Godbey
Original Assignee
Minnesota Mining & Mfg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Minnesota Mining & Mfg filed Critical Minnesota Mining & Mfg
Publication of MX9804871A publication Critical patent/MX9804871A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)

Abstract

Se proporciona un dispositivo de suministro de medicamento transdérmico que involucra un copolímero basado en acrilato o metacrilato, un mejorador de penetracion cutánea, un polímero de polivinilpirrolidona y una cantidad terapéuticamente efectiva de flurbiprofeno.
MX9804871A 1995-12-22 1998-06-17 Dispositivo transdermico para suministro de flurbiprofeno. MX9804871A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/577,482 US5702720A (en) 1995-12-22 1995-12-22 Transdermal device for the delivery of flurbiprofen

Publications (1)

Publication Number Publication Date
MX9804871A true MX9804871A (es) 1998-10-31

Family

ID=24308917

Family Applications (2)

Application Number Title Priority Date Filing Date
MX9804871A MX9804871A (es) 1995-12-22 1998-06-17 Dispositivo transdermico para suministro de flurbiprofeno.
MX9804969A MX9804969A (es) 1995-12-22 1998-06-19 Dispositivo de distribucion de farmaco.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX9804969A MX9804969A (es) 1995-12-22 1998-06-19 Dispositivo de distribucion de farmaco.

Country Status (22)

Country Link
US (2) US5702720A (es)
EP (2) EP0869781B1 (es)
JP (2) JP2000503638A (es)
KR (2) KR19990076588A (es)
CN (2) CN1098071C (es)
AR (1) AR005163A1 (es)
AT (2) ATE241350T1 (es)
AU (2) AU701782B2 (es)
CA (2) CA2238400A1 (es)
CO (1) CO4810224A1 (es)
CZ (2) CZ197298A3 (es)
DE (2) DE69628448T2 (es)
HR (1) HRP960608B1 (es)
HU (1) HUP9901991A3 (es)
IL (2) IL124629A (es)
MX (2) MX9804871A (es)
MY (1) MY113685A (es)
NO (2) NO982613L (es)
NZ (2) NZ325659A (es)
TW (1) TW436298B (es)
WO (2) WO1997023205A1 (es)
ZA (1) ZA9610729B (es)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5252334A (en) * 1989-09-08 1993-10-12 Cygnus Therapeutic Systems Solid matrix system for transdermal drug delivery
JP3782834B2 (ja) * 1994-10-26 2006-06-07 株式会社トクホン 鎮痛抗炎症貼付剤
DE19830649C2 (de) 1998-07-09 2003-04-10 Lohmann Therapie Syst Lts Topisches Pflaster mit nichtsteroidalen Antirheumatika mit Säuregruppe
DE19834496B4 (de) 1998-07-31 2004-02-26 Beiersdorf Ag Verbesserte Freisetzung von Ibuprofen aus Heißschmelzklebemassen in wirkstoffhaltigen Pflastern durch Zusatz von pharmazeutischen Hilfsstoffen und Verwendung von Hilfsstoffen zur Verbesserung der Freisetzung von Ibuprofen
WO2000010531A1 (en) 1998-08-19 2000-03-02 Rtp Pharma Inc. Injectable aqueous dispersions of propofol
DE19840191A1 (de) * 1998-09-03 2000-03-09 Lohmann Therapie Syst Lts Arzneistoffhaltiges Pflaster mit drei funktionalen Schichten
US7052714B1 (en) * 1999-10-13 2006-05-30 Senju Pharmaceutical Co., Ltd Ophthalmic adhesive preparations for percutaneous adsorption
US20020110585A1 (en) 1999-11-30 2002-08-15 Godbey Kristin J. Patch therapeutic agent delivery device having texturized backing
US6455067B1 (en) * 2000-05-24 2002-09-24 Sang-A Pharmaceutical Co., Ltd. Transdermal patch for nonsteroidal antiinflammatory drug(s)
DE10032537A1 (de) * 2000-07-05 2002-01-31 Labtec Gmbh Dermales System, enthaltend 2-(3-Benzophenyl)Propionsäure
DE10049225A1 (de) * 2000-09-28 2002-04-11 Labtec Gmbh Dermales System, enthaltend Diclofenac
AU2002235155A1 (en) * 2000-12-05 2002-06-18 Noven Pharmaceuticals, Inc. Crystallization inhibition of drugs in transdermal drug delivery systems
US7803392B2 (en) * 2000-12-27 2010-09-28 University Of Kentucky Research Foundation pH-Sensitive mucoadhesive film-forming gels and wax-film composites suitable for topical and mucosal delivery of molecules
US6479076B2 (en) * 2001-01-12 2002-11-12 Izhak Blank Nicotine delivery compositions
RU2358699C2 (ru) * 2001-06-18 2009-06-20 Ноувен Фамэсьютикэлз, Инк. Композиция для чрескожной доставки лекарственного средства (варианты), способ ее получения и использование
US6805878B2 (en) * 2001-09-13 2004-10-19 Noven Pharmaceuticals, Inc. Transdermal administration of ACE inhibitors
US6951642B2 (en) * 2001-09-28 2005-10-04 3M Innovative Properties Company Water-in-oil emulsions with anionic groups, compositions, and methods
US7030203B2 (en) 2001-09-28 2006-04-18 3M Innovative Properties Company Water-in-oil emulsions with ethylene oxide groups, compositions, and methods
US20030124174A1 (en) * 2001-10-25 2003-07-03 Endo Pharmaceuticals, Inc Method for treating non-neuropathic pain
US20030152612A1 (en) * 2002-01-03 2003-08-14 Pugliese Peter T. Method and article to control cellulite
US6838078B2 (en) * 2002-01-16 2005-01-04 3M Innovative Properties Company Film-forming compositions and methods
US7147873B2 (en) 2002-01-16 2006-12-12 3M Innovative Properties Company Antiseptic compositions and methods
DE10212864B4 (de) * 2002-03-22 2005-12-22 Beiersdorf Ag Polymermatrizes umfassend ein Mischsystem zur Löslichkeitsvermittlung von pharmazeutischen Wirkstoffen, Verfahren zu deren Herstellung und deren Verwendung
KR100517101B1 (ko) * 2002-07-31 2005-09-27 한국과학기술연구원 이중 자극 응답성 하이드로젤 및 이의 제조 방법
US20040062794A1 (en) * 2002-09-30 2004-04-01 Lee Shulman 17Beta- estradiol/levonorgestrel transdermal patch for hormone replacement therapy
US7479132B2 (en) 2003-03-10 2009-01-20 Tokuyama Corporation Patch material for ionic medicine administration
CA2529852A1 (en) * 2003-06-20 2004-12-29 Viral Genomix, Inc. Compositions for and methods for treating hiv
US20050065062A1 (en) * 2003-09-24 2005-03-24 3M Innovative Properties Company Method of formulating a pharmaceutical composition
CA2556422A1 (en) 2004-02-17 2005-08-01 Cook Biotech Incorporated Medical devices and methods for applying bolster material
ES2596809T3 (es) * 2004-10-08 2017-01-12 Noven Pharmaceuticals, Inc. Dispositivo de administración transdérmica de fármacos que incluye un refuerzo oclusivo
BRPI0419274B8 (pt) * 2004-11-05 2021-05-25 Lead Chem Co Ltd preparação não aquosa para absorção percutânea contendo analgésico não-esteroidal
KR100663163B1 (ko) 2005-10-24 2007-01-02 (주)아모레퍼시픽 비스테로이드성 소염진통제를 함유하는 경피 투여 제제
CN101541314A (zh) * 2006-06-14 2009-09-23 爱若涂层制品有限公司 向人、动物和植物递送活性成分的装置
KR20080006960A (ko) * 2006-07-14 2008-01-17 (주)아모레퍼시픽 소수성 비스테로이드성 소염진통제를 함유하는 경피 투여제제
US20080039415A1 (en) * 2006-08-11 2008-02-14 Gregory Robert Stewart Retrograde transport of sirna and therapeutic uses to treat neurologic disorders
JP5214223B2 (ja) * 2007-11-15 2013-06-19 船井電機株式会社 プロジェクタ
CA2709808A1 (en) * 2008-05-21 2009-11-26 Teikoku Pharma Usa, Inc. Treatment of dysmenorrhea via transdermal administration of nonsteroidal anti-inflammatory drugs
WO2010077096A2 (ko) * 2008-12-31 2010-07-08 한올바이오파마주식회사 약물전달기구
US20100291182A1 (en) * 2009-01-21 2010-11-18 Arsenal Medical, Inc. Drug-Loaded Fibers
US8850719B2 (en) 2009-02-06 2014-10-07 Nike, Inc. Layered thermoplastic non-woven textile elements
US20100199520A1 (en) * 2009-02-06 2010-08-12 Nike, Inc. Textured Thermoplastic Non-Woven Elements
US8906275B2 (en) 2012-05-29 2014-12-09 Nike, Inc. Textured elements incorporating non-woven textile materials and methods for manufacturing the textured elements
US20100199406A1 (en) 2009-02-06 2010-08-12 Nike, Inc. Thermoplastic Non-Woven Textile Elements
US9682512B2 (en) 2009-02-06 2017-06-20 Nike, Inc. Methods of joining textiles and other elements incorporating a thermoplastic polymer material
CN101502499B (zh) * 2009-03-13 2011-07-27 北京化工大学 一种布洛芬经皮释放贴剂及其制备方法
US9173817B2 (en) 2009-08-24 2015-11-03 Arsenal Medical, Inc. In situ forming hemostatic foam implants
US9044580B2 (en) 2009-08-24 2015-06-02 Arsenal Medical, Inc. In-situ forming foams with outer layer
US20110202016A1 (en) * 2009-08-24 2011-08-18 Arsenal Medical, Inc. Systems and methods relating to polymer foams
US10420862B2 (en) 2009-08-24 2019-09-24 Aresenal AAA, LLC. In-situ forming foams for treatment of aneurysms
EP2504367A4 (en) * 2009-11-23 2015-10-14 Isp Investments Inc REACTIVE SOLUTION OF POLYMERIZABLE POLYMERS COMPRISING POLYMERIZABLE REACTIVE FUNCTIONAL VALUES, METHOD THEREFOR, AND COMPOSITIONS CONTAINING SAME
US9034240B2 (en) 2011-01-31 2015-05-19 Arsenal Medical, Inc. Electrospinning process for fiber manufacture
US9194058B2 (en) 2011-01-31 2015-11-24 Arsenal Medical, Inc. Electrospinning process for manufacture of multi-layered structures
US8968626B2 (en) 2011-01-31 2015-03-03 Arsenal Medical, Inc. Electrospinning process for manufacture of multi-layered structures
US8993831B2 (en) 2011-11-01 2015-03-31 Arsenal Medical, Inc. Foam and delivery system for treatment of postpartum hemorrhage
US20130255103A1 (en) 2012-04-03 2013-10-03 Nike, Inc. Apparel And Other Products Incorporating A Thermoplastic Polymer Material
ITMI20121428A1 (it) * 2012-08-10 2014-02-11 Allergosystem S R L Dispositivo per applicazione topica di medicamenti o cosmetici
CN105992596A (zh) * 2014-01-29 2016-10-05 日东电工株式会社 皮肤渗透促进组合物、经皮给药制剂及贴附制剂
IL247927B (en) 2014-05-07 2022-09-01 Boehringer Ingelheim Int Container, nebulizer and use
KR102774558B1 (ko) 2015-12-30 2025-03-04 코리움, 엘엘씨 장기 경피 투여를 위한 시스템 및 방법
WO2018074261A1 (ja) * 2016-10-17 2018-04-26 第一三共株式会社 封入容器の製造方法及び製造装置
CN110114064A (zh) 2016-12-28 2019-08-09 久光制药株式会社 贴剂
US11872320B2 (en) 2021-02-25 2024-01-16 Hisamitsu Pharmaceutical Co., Inc. Method for treating osteoarthritis
CN113648297B (zh) * 2021-08-16 2023-07-14 乐明药业(苏州)有限公司 一种含有氟比洛芬的药物组合物与贴剂
WO2024145319A1 (en) * 2022-12-28 2024-07-04 Corium, Llc Method of preparing transdermal delivery system
WO2024145323A1 (en) * 2022-12-28 2024-07-04 Corium, Llc Pre-mixing method of preparing transdermal delivery system

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US24906A (en) * 1859-07-26 Simeon goodfellow
USRE24906E (en) * 1955-11-18 1960-12-13 Pressure-sensitive adhesive sheet material
US3949128A (en) * 1972-08-22 1976-04-06 Kimberly-Clark Corporation Product and process for producing a stretchable nonwoven material from a spot bonded continuous filament web
US4185100A (en) * 1976-05-13 1980-01-22 Johnson & Johnson Topical anti-inflammatory drug therapy
JPS55139313A (en) * 1979-04-16 1980-10-31 Ota Seiyaku Kk Gel cream composition comprising higher fatty acid ethanol amide, and drug containing it
GB2075837B (en) * 1980-05-14 1984-03-14 Hisamitsu Pharmaceutical Co Topical pharmaceutical gel containing anti-inflammatory analgesic agents
US5445604A (en) * 1980-05-22 1995-08-29 Smith & Nephew Associated Companies, Ltd. Wound dressing with conformable elastomeric wound contact layer
JPS5855411A (ja) * 1981-09-28 1983-04-01 Nitto Electric Ind Co Ltd 基剤組成物および外用医薬組成物
US4473584A (en) * 1982-12-06 1984-09-25 The Upjohn Company Treatment of Type I Herpes virus with flurbiprofen
US4477468A (en) * 1982-12-06 1984-10-16 The Upjohn Company Treatment of type II herpes virus with flurbiprofen
US4701470A (en) * 1982-12-06 1987-10-20 The Upjohn Company Treatment of Type II Herpes virus with ibuprofen
JPS59222409A (ja) * 1983-06-01 1984-12-14 Nippon Redarii Kk 消炎鎮痛ゲル軟膏剤
CH662944A5 (it) * 1984-10-18 1987-11-13 Pier Luigi Prof Dr Luisi Procedimento per la preparazione di biocompatibili di micelle inverse di biocompatibili e loro utilizzazione.
US4751087A (en) * 1985-04-19 1988-06-14 Riker Laboratories, Inc. Transdermal nitroglycerin delivery system
DE3522550A1 (de) * 1985-06-24 1987-01-02 Klinge Co Chem Pharm Fab Aufspruehbare pharmazeutische zubereitung fuer die topische anwendung
DE3532562A1 (de) * 1985-09-12 1987-03-12 Dolorgiet Gmbh & Co Kg Transdermal resorbierbare, wasserhaltige zubereitungen von arylpropionsaeurederivaten und verfahren zur herstellung derselben
GB8701392D0 (en) * 1987-01-22 1987-02-25 Boots Co Plc Therapeutic agents
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
GB2217595B (en) * 1988-04-21 1991-11-20 American Cyanamid Co Antiinflammatory gel
US5230701A (en) * 1988-05-13 1993-07-27 Minnesota Mining And Manufacturing Company Elastomeric adhesive and cohesive materials
US5266723A (en) * 1989-05-16 1993-11-30 Medice, Ltd., Chem.-Pharm. Fabrik Putter Gmbh & Co. Kg Process for the preparation of optically active 2-aryl-alkanoic acids, especially 2-aryl-propionic acids
AU6758990A (en) * 1989-11-06 1991-05-31 Sepracor, Inc. Analgesic composition containing optically pure s(+) flurbiprofen
US5093133A (en) * 1990-01-24 1992-03-03 Mcneil-Ppc, Inc. Method for percutaneous delivery of ibuprofen using hydroalcoholic gel
AU7850491A (en) * 1990-05-18 1991-12-10 Analgesic Associates Prevention or treatment of sunburn using the s(+) isomer of flurbiprofen
DE4028906A1 (de) * 1990-09-12 1992-03-19 Paz Arzneimittelentwicklung Arzneimittel sowie deren herstellung und deren verwendung bei der bekaempfung von schmerzen und/oder entzuendungen und/oder fieber an tieren und menschen
TW218849B (es) * 1991-05-17 1994-01-11 Bristol Myers Squibb Co
ATE176153T1 (de) * 1991-08-30 1999-02-15 Hisamitsu Pharmaceutical Co Entzündungshemmendes, analgetisches pflaster
DE4210711A1 (de) * 1991-10-31 1993-05-06 Schering Ag Berlin Und Bergkamen, 1000 Berlin, De Transdermale therapeutische systeme mit kristallisationsinhibitoren
GB2273044B (en) * 1992-12-02 1997-04-09 Pacific Chem Co Ltd Medicinal patches for percutaneous administration
EP0695179A1 (en) * 1993-04-22 1996-02-07 Minnesota Mining And Manufacturing Company Transdermal antiinflammatory composition

Also Published As

Publication number Publication date
DE69628762T2 (de) 2004-04-29
AU714798B2 (en) 2000-01-13
WO1997023205A1 (en) 1997-07-03
NO982613L (no) 1998-08-21
CO4810224A1 (es) 1999-06-30
CA2238400A1 (en) 1997-07-03
EP0869781B1 (en) 2003-05-28
TW436298B (en) 2001-05-28
IL124629A0 (en) 1998-12-06
NO982764D0 (no) 1998-06-15
HRP960608B1 (en) 2001-12-31
AU701782B2 (en) 1999-02-04
CN1098069C (zh) 2003-01-08
CN1098071C (zh) 2003-01-08
US5702720A (en) 1997-12-30
HUP9901991A3 (en) 2001-04-28
CN1205630A (zh) 1999-01-20
NO982764L (no) 1998-06-15
HUP9901991A2 (hu) 1999-10-28
NZ325125A (en) 2000-05-26
CZ197198A3 (cs) 1998-11-11
JP2000502349A (ja) 2000-02-29
AU1422097A (en) 1997-07-17
KR19990076589A (ko) 1999-10-15
MX9804969A (es) 1998-09-30
CN1205631A (zh) 1999-01-20
MY113685A (en) 2002-04-30
IL124629A (en) 2001-10-31
NZ325659A (en) 2000-02-28
NO982613D0 (no) 1998-06-05
DE69628448T2 (de) 2004-04-08
ATE243031T1 (de) 2003-07-15
HRP960608A2 (en) 1997-10-31
KR100452001B1 (ko) 2004-12-30
IL124804A0 (en) 1999-01-26
AR005163A1 (es) 1999-04-14
CZ197298A3 (cs) 1999-01-13
EP0868177B1 (en) 2003-06-18
CA2240349A1 (en) 1997-07-03
JP2000503638A (ja) 2000-03-28
US6086911A (en) 2000-07-11
WO1997023206A1 (en) 1997-07-03
DE69628448D1 (de) 2003-07-03
DE69628762D1 (de) 2003-07-24
EP0869781A1 (en) 1998-10-14
AU1295097A (en) 1997-07-17
KR19990076588A (ko) 1999-10-15
ZA9610729B (en) 1998-06-19
IL124804A (en) 2001-12-23
EP0868177A1 (en) 1998-10-07
ATE241350T1 (de) 2003-06-15

Similar Documents

Publication Publication Date Title
MY113685A (en) Transdermal device for the delivery of flurbiprofen
GR3033859T3 (en) Matrix for transdermal drug delivery
DE69530177T2 (de) Als löslichkeit-steigernde gebrauchte polyvinylpyrrolidon enthaltende transdermale vorrichtung
ATE200028T1 (de) Transdermale abgabe vorrichtung
DK0840621T3 (es)
ZA944608B (en) Incorporating poly-N-vinyl amide in a transdermal system
AU4853796A (en) Self-retracting medical needle apparatus and methods
NO941593D0 (es)
MX9701968A (es) Emplasto de escopolamina.
IL128768A0 (en) Transdermal therapeutic system containing oestriol
TH29691B (th) เครื่องมือผ่านผิวหนังสำหรับการให้เฟลอร์บิโพรเฟม
MX9709013A (es) Forma de dosis que comprende oxibutinina.

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees